Skip to main content
Menu
Home
1-800-448-0440
(1 p.m. to 4 p.m. ET)
ContactUs@HIVinfo.NIH.gov
Search
Site Search
Close

Main navigation

  • Home
  • Understanding HIV
  • Resources
  • Contact Us
  • English
  • Español (Spanish)
  1. Home
  2. Understanding HIV
  3. Infographic
  4. FDA Approval Of HIV Medicines
COVID-19

Get the latest public health information from CDC

Get the latest research information from NIH | Español

FDA Approval of HIV Medicines

A timeline with all the FDA approval dates for HIV medicines, categorized by drug class.

CAB and RPV, CAB plus RPV, Cabenuva kit, cabotegravir extended-release injectable suspension and rilpivirine extended-release injectable suspension
Download Print
CLICK TO ENLARGE
Next Infographic HIV and Birth Control
  • HIV Drug Resistance

Connect with us

connect with us by Twitter
Twitter
connect with us by Facebook
Facebook
connect with us by Instagram
Instagram
connect with us by Subscribe
Subscribe

Mobile apps

GUIDELINES ios app GUIDELINES android app
GUIDELINES
DRUG DATABASE ios app DRUG DATABASE android app
DRUG DATABASE
GLOSSARY ios app GLOSSARY android app
GLOSSARY

Language

EnglishEspañol

Footer

  • Understanding HIV
  • Resources
  • About
  • Freedom of Information Act

External sources

  • ClinicalInfo.HIV.gov
  • NIH.gov
  • OIG.HHS.gov
  • USA.gov
  • Visitor Information
  • FAQs
  • Web Policies and Notices
  • No Fear Act

Provided in collaboration with NIH’s Office of Aids Research.